Rayonier Advanced Materials (RYAM) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net sales reached $419 million, up $34 million year-over-year, with net income of $11 million versus a $17 million loss in the prior year quarter, and adjusted EBITDA of $68 million, up $41 million year-over-year, driven by higher cellulose specialties sales, cost reductions, and productivity gains.
Adjusted Free Cash Flow for Q2 2024 was $69 million, aided by a $39 million sale of softwood lumber duty refund rights.
Indefinite suspension of the Temiscaming HPC plant began in July 2024, expected to improve free cash flow and Adjusted EBITDA for the year by $25–$30 million, despite one-time charges.
Full-year 2024 Adjusted EBITDA guidance raised to $205–$215 million; Adjusted Free Cash Flow guidance increased to $100–$110 million.
Progress made on biomaterials strategy, with the Tartas bioethanol facility operational and expected to contribute $3–$4 million EBITDA in 2024.
Financial highlights
Q2 2024 gross margin was $48 million, up from $15 million in Q2 2023; operating income was $28 million, a $35 million improvement year-over-year.
Net income for Q2 2024 was $11 million ($0.12–$0.17 per share), compared to a net loss of $1–$17 million in Q2 2023.
Adjusted EBITDA for Q2 2024 was $68 million, up from $27 million in Q2 2023.
CapEx year-to-date was $58 million, including $28 million for strategic projects.
Net secured debt at quarter-end was $659 million, with a covenant net secured debt ratio of 3.4x.
Outlook and guidance
2024 Adjusted EBITDA expected at $205–$215 million; Adjusted Free Cash Flow at $100–$110 million.
Suspension of Temiscaming HPC plant expected to increase 2024 Adjusted EBITDA and free cash flow by $25–$30 million, despite one-time charges.
High Purity Cellulose prices projected to rise slightly in 2024; volumes to increase due to competitor closure and pre-suspension sales.
Paperboard prices expected to decline slightly in H2 2024, with volumes increasing; High-Yield Pulp prices to decline but volumes to rise.
Actively pursuing refinancing of 2026 Senior Notes before January 2025, with Houlihan Lokey engaged for options.
Latest events from Rayonier Advanced Materials
- Board refresh, CEO change, and governance reforms highlight a focus on accountability and performance.RYAM
Proxy filing20 Mar 2026 - 2026 targets positive cash flow, EBITDA growth, and new product launches amid disciplined execution.RYAM
Gabelli Funds Annual Specialty Chemicals Symposium20 Mar 2026 - 2025 results showed lower revenue and EBITDA, with 2026 targeting free cash flow recovery.RYAM
Q4 20254 Mar 2026 - Aiming to double EBITDA by 2027, leveraging price, cost, and biomaterials growth.RYAM
17th Annual Southwest IDEAS Conference3 Feb 2026 - Transformation to specialty cellulose, innovation, and sustainability drive growth and profitability.RYAM
Fireside Chat3 Feb 2026 - Shifting to specialty cellulose and biomaterials, with debt reduction and margin expansion in focus.RYAM
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Shifting to specialty cellulose and biomaterials, with asset sales and debt reduction underway.RYAM
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Q3 net sales and Adjusted EBITDA surged, 2024 guidance held, and $700M refinancing secured.RYAM
Q3 202416 Jan 2026 - Focus on specialty cellulose, biomaterials, and debt reduction drives margin and cash flow growth.RYAM
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025